Gynecologic Cancers: Vulvar Cancer

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Vulvar cancer, a rare gynecologic malignancy, was historically associated with postmenopausal women.
• Recent data indicate a rise in premenopausal vulvar cancer incidence, linked to human papillomavirus (HPV) infection.
• Family physicians serve as primary care points for reproductive-age individuals, highlighting their role in early intervention.

Purpose of the Study:

• To emphasize the critical role of family physicians in recognizing and managing vulvar cancer.
• To advocate for early detection strategies and risk factor modification, including HPV vaccination.
• To reduce diagnostic delays and improve patient outcomes for vulvar cancer.

Main Methods:

• Review of epidemiologic data on vulvar cancer trends.
• Emphasis on the importance of routine gynecologic examinations including perineal visualization.
• Discussion of risk factor identification (e.g., lichen sclerosus) and diagnostic procedures like biopsy.
• Outline of treatment modalities based on cancer stage (e.g., vulvectomy, radiation, chemotherapy).

Main Results:

• Vulvar cancer diagnosis is often delayed by approximately two years from initial presentation.
• Human papillomavirus infection is a significant factor in the increasing rates among younger women.
• Early identification and management of vulvar pathology and risk factors are essential for timely diagnosis and treatment.

Conclusions:

• Enhanced physician awareness and patient education are vital for reducing diagnostic delays in vulvar cancer.
• Routine screening and prompt management of suspicious lesions can significantly improve patient survival.
• Comprehensive survivorship care tailored to individual gynecologic and general health needs is recommended.